MOLECULIN BIOTECH INC
MBRX · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $0.43
- Today’s Low
- $0.41
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.45
- Previous Close
- $0.41
- Volume
- 173.91K
- Market Cap
- $8.43M
- P/E Ratio
- --
- EPS
- $-14.53
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 5300 MEMORIAL DRIVE, HOUSTON, TX, UNITED STATES, 77007
- Country
- US
- Listing Date
- 2016-06-02
- Fiscal Year End
- December
- Shares Outstanding
- 7.07M
- CIK
- 0001659617
- Website
- moleculin.com
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant viruses and tumors in the United States. The company is headquartered in Houston, Texas.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$7.56M
2026-03-31
$7.87M
2025-12-31
$7.53M
2025-09-30
$5.9M
Net Income
2026-06-30
-$7.63M
2026-03-31
-$12.84M
2025-12-31
$15.55M
2025-09-30
-$25.39M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-1.40
2026-03-31
$-3.54
2025-12-31
$4.82
2025-09-30
$-0.68
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$7.55M
2026-03-31
-$12.83M
2025-12-31
$15.56M
2025-09-30
-$25.37M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $7.56M | $7.87M | $7.53M | $5.9M |
| Net Income | -$7.63M | -$12.84M | $15.55M | -$25.39M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-1.40 | $-3.54 | $4.82 | $-0.68 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$7.55M | -$12.83M | $15.56M | -$25.37M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.